Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spami is a specialized engineering company that designs and manufactures high-speed production lines for pharmaceutical glass containers. As the machinery division of the Stevanato Group, Spami provides the advanced technology required to convert glass tubing into high-quality vials, ampoules, cartridges, and syringes. The company's expertise includes precision glass forming, automated handling, and integrated vision inspection systems to ensure zero-defect manufacturing. Their solutions are utilized globally by pharmaceutical companies and glass converters to produce primary packaging for injectable drugs. By focusing on innovation in automation and digitalization, Spami supports the evolving needs of the healthcare industry for safe and efficient drug delivery components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spami.